skip to Main Content

Quantifying autophagy using novel LC3B and p62 TR-FRET assays.

By Bresciani, Alberto; Spiezia, Maria Carolina; Boggio, Roberto; Cariulo, Cristina; Nordheim, Anja; Altobelli, Roberta; Kuhlbrodt, Kirsten; Dominguez, Celia; Munoz-Sanjuan, Ignacio; Wityak, John; et al
From PLoS One (2018), 13(3), e0194423/1-e0194423/18. Language: English, Database: CAPLUS, DOI:10.1371/journal.pone.0194423

Autophagy is a cellular mechanism that can generate energy for cells or clear misfolded or aggregated proteins, and upregulating this process has been proposed as a therapeutic approach for neurodegenerative diseases. Here we describe a novel set of LC3B-II and p62 time-resolved fluorescence resonance energy transfer (TR-FRET) assays that can detect changes in autophagy in the absence of exogenous labels. Lipidated LC3 is a marker of autophagosomes, while p62 is a substrate of autophagy. These assays can be employed in high-throughput screens to identify novel autophagy upregulators, and can measure autophagy changes in cultured cells or tissues after genetic or pharmacol. interventions. We also demonstrate that different cells exhibit varying autophagic responses to pharmacol. interventions. Overall, it is clear that a battery of readouts is required to make conclusions about changes in autophagy.

More info on PubMed.gov

IRBM IN THE NEWS

PRESS RELEASES

EVENTS

Back To Top